Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Erectile Dysfunction

Free Subscription Articles published in J Urol Retrieve available abstracts of 43 articles: HTML format

Single Articles

May 2025
1. DIETRICH P, Werner Z
   Editorial Comment: A Prospective Randomized Study on Low-Energy Extracorporeal Shockwave Therapy (LI-SWT) for Erectile Dysfunction After Radical Prostatectomy.
   J Urol. 2025 May 23:101097JU0000000000004609. doi: 10.1097/JU.0000000000004609.
   PubMed    
   
   
   
2. DMOCHOWSKI R
   Editorial Comment: A Prospective Randomized Study on Low-Energy Extracorporeal Shockwave Therapy (LI-SWT) for Erectile Dysfunction After Radical Prostatectomy.
   J Urol. 2025 May 23:101097JU0000000000004607. doi: 10.1097/JU.0000000000004607.
   PubMed    
   
   
   
3. JEFFERY J, Punjani N
   Editorial Comment on "A Prospective Randomized Study on Low-Energy Extracorporeal Shockwave Therapy (LI-SWT) for Erectile Dysfunction After Radical Prostatectomy".
   J Urol. 2025 May 23:101097JU0000000000004608. doi: 10.1097/JU.0000000000004608.
   PubMed    
   
   
   April 2025
4. PEDERSEN TB, Secher C, Moumneh A, Hvid N, et al
   A Prospective Randomized Study on Low-Energy Extracorporeal Shockwave Therapy for Erectile Dysfunction After Radical Prostatectomy.
   J Urol. 2025 Apr 28:101097JU0000000000004576. doi: 10.1097/JU.0000000000004576.
   PubMed     Abstract available
   
   
   February 2025
5. PANDIT K, Morgan K, Riviere P, Dabbas M, et al
   Reply: Incidence of Erectile Dysfunction and Testosterone Deficiency in Testicular Cancer Survivors.
   J Urol. 2025 Feb 12:101097JU0000000000004461. doi: 10.1097/JU.0000000000004461.
   PubMed    
   
   
   
6. WANG W, Gao C, Fu K
   Letter: Incidence of Erectile Dysfunction and Testosterone Deficiency in Testicular Cancer Survivors.
   J Urol. 2025 Feb 3:101097JU0000000000004440. doi: 10.1097/JU.0000000000004440.
   PubMed    
   
   
   September 2024
7. PANDIT K, Riviere P, Morgan K, Nelson T, et al
   Incidence of Erectile Dysfunction and Testosterone Deficiency in Testicular Cancer Survivors.
   J Urol. 2024 Sep 30:101097JU0000000000004259. doi: 10.1097/JU.0000000000004259.
   PubMed     Abstract available
   
   
   February 2024
8. GREENBERG DR, Panken EJ, Amarasekera C
   Platelet-Rich Plasma for Urologic Conditions: An Early Call for Composition Reporting.
   J Urol. 2024;211:313-316.
   PubMed    
   
   
   December 2023
9. SEFTEL AD
   Male and Female Sexual Function and Dysfunction; Andrology.
   J Urol. 2023;210:917-918.
   PubMed    
   
   
   November 2023
10. MASTERSON TA, Molina M, Ledesma B, Zucker I, et al
    Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial. Reply.
    J Urol. 2023;210:734-735.
    PubMed    
    
    
    
11. GREEN B, Flores A, Warner J, Kohler T, et al
    Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial.
    J Urol. 2023;210:791-802.
    PubMed     Abstract available
    
    
    
12. SINGHAL U, Hollenbeck BK, Kaffenberger SD, Salami SS, et al
    Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice.
    J Urol. 2023;210:771-777.
    PubMed     Abstract available
    
    
    October 2023
13. PARK SH, Wilson SK, Wen L
    Subcoronal Incision for Inflatable Penile Prosthesis Does Not Risk Glans Necrosis.
    J Urol. 2023;210:678-687.
    PubMed     Abstract available
    
    
    September 2023
14. KALYVIANAKIS D, Poulios E, Mykoniatis I, Pyrgidis N, et al
    Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial. Letter.
    J Urol. 2023 Sep 6:101097JU0000000000003684. doi: 10.1097/JU.0000000000003684.
    PubMed    
    
    
    
15. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2023;210:555-556.
    PubMed    
    
    
    
16. RAGUE JT, Hirsch J, Meyer T, Streur C, et al
    "I Just Haven't Done Any of That": Applicability of the International Index of Erectile Function in Young Men With Spina Bifida.
    J Urol. 2023;210:538-547.
    PubMed     Abstract available
    
    
    August 2023
17. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2023;210:368-370.
    PubMed    
    
    
    July 2023
18. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2023;210:206-207.
    PubMed    
    
    
    June 2023
19. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2023;209:1218-1221.
    PubMed    
    
    
    May 2023
20. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2023;209:1013-1014.
    PubMed    
    
    
    
21. RIVERO MJ, Ory J, Diaz P, Thirumavalavan N, et al
    Comparison of Hematocrit Change in Testosterone-Deficient Men Treated With Intranasal Testosterone Gel vs Intramuscular Testosterone Cypionate: A Randomized Clinical Trial.
    J Urol. 2023 May 1:101097JU0000000000003487. doi: 10.1097/JU.0000000000003487.
    PubMed     Abstract available
    
    
    April 2023
22. MASTERSON TA, Molina M, Ledesma B, Zucker I, et al
    Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial.
    J Urol. 2023 Apr 30:101097JU0000000000003481. doi: 10.1097/JU.0000000000003481.
    PubMed     Abstract available
    
    
    
23. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2023;209:795-797.
    PubMed    
    
    
    March 2023
24. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2023;209:621-622.
    PubMed    
    
    
    February 2023
25. BARHAM DW, Pyrgidis N, Gross MS, Hammad M, et al
    AUA-recommended Antibiotic Prophylaxis for Primary Penile Implantation Results in a Higher, Not Lower, Risk for Postoperative Infection: A Multicenter Analysis.
    J Urol. 2023;209:399-409.
    PubMed     Abstract available
    
    
    
26. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2023;209:432.
    PubMed    
    
    
    January 2023
27. SAFARINEJAD MR
    Expression of Concern: Evaluation of the Safety and Efficacy of Sildenafil Citrate for Erectile Dysfunction in Men With Multiple Sclerosis: A Double-Blind, Placebo Controlled, Randomized Study.
    J Urol. 2023 Jan 10:101097JU0000000000003114. doi: 10.1097/JU.0000000000003114.
    PubMed    
    
    
    
28. SAFARINEJAD MR, Shafiei N, Safarinejad S
    Expression of Concern: The Influence of Promoter -202 A/C Polymorphism (rs2854744) of the IGFBP-3 Gene on Erectile Dysfunction Risk and Serum Levels of IGF-I and IGFBP-3.
    J Urol. 2023 Jan 10:101097JU0000000000003142. doi: 10.1097/JU.0000000000003142.
    PubMed    
    
    
    
29. MULLOY E, Li S, Belladelli F, Del Giudice F, et al
    The Risk of Cardiovascular and Cerebrovascular Disease in Men With a History of Priapism.
    J Urol. 2023;209:253-260.
    PubMed     Abstract available
    
    
    December 2022
30. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2022;208:1333-1335.
    PubMed    
    
    
    November 2022
31. DE LA ROSETTE J, Dominguez-Escrig J, Zhang K, Teoh J, et al
    A Multicenter, Randomized, Single-blind, 2-Arm Intervention Study Evaluating the Adverse Events and Quality of Life After Irreversible Electroporation for the Ablation of Localized Low-intermediate Risk Prostate Cancer.
    J Urol. 2022 Nov 28:101097JU0000000000003051. doi: 10.1097/JU.0000000000003051.
    PubMed     Abstract available
    
    
    
32. MARTINI A, Valerio M
    An Algorithm to Personalize Nerve Sparing in Men With Unilateral High-risk Prostate Cancer. Reply.
    J Urol. 2022 Nov 11:101097JU0000000000003055. doi: 10.1097/JU.0000000000003055.
    PubMed    
    
    
    
33. BOWER PE
    An Algorithm to Personalize Nerve Sparing in Men With Unilateral High-risk Prostate Cancer. Letter.
    J Urol. 2022 Nov 11:101097JU0000000000003054. doi: 10.1097/JU.0000000000003054.
    PubMed    
    
    
    
34. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2022;208:1146-1148.
    PubMed    
    
    
    October 2022
35. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2022;208:917-919.
    PubMed    
    
    
    September 2022
36. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2022;208:720-723.
    PubMed    
    
    
    August 2022
37. KALYVIANAKIS D, Mykoniatis I, Pyrgidis N, Kapoteli P, et al
    The Effect of Low-Intensity Shock Wave Therapy on Moderate Erectile Dysfunction: A Double-Blind, Randomized, Sham-Controlled Clinical Trial.
    J Urol. 2022;208:388-395.
    PubMed     Abstract available
    
    
    
38. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2022;208:459-461.
    PubMed    
    
    
    July 2022
39. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2022;208:197-200.
    PubMed    
    
    
    June 2022
40. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2022;207:1332-1335.
    PubMed    
    
    
    May 2022
41. SEFTEL AD
    Male/Female Sexual Function/Dysfunction, Andrology.
    J Urol. 2022;207:1137-1139.
    PubMed    
    
    
    April 2022
42. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2022;207:911-913.
    PubMed    
    
    
    December 2021
43. SHINDEL AW, Althof SE, Carrier S, Chou R, et al
    Disorders of Ejaculation: An AUA/SMSNA Guideline.
    J Urol. 2021 Dec 28:101097JU0000000000002392. doi: 10.1097/JU.0000000000002392.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Erectile Dysfunction is free of charge.